{"DataElement":{"publicId":"2866388","version":"1","preferredName":"Laboratory Procedure HTLV-1 HTLV-2 Antibody Date","preferredDefinition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._A human immunodeficiency virus; a species of lentivirus causing leukemia and sometimes a mild immunodeficiency._A human retrovirus associated with T-cell hairy cell leukemia._A type of protein made by B lymphocytes in response to a foreign substance (antigen). Each antibody only binds to a specific antigen, helping to destroy the antigen directly or by assisting white blood cells to destroy the antigen._The particular day, month and year an event has happened or will happen.","longName":"LAB_HTLV_AB_DT","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2693355","version":"1","preferredName":"Laboratory Procedure HTLV-1 HTLV-2 Antibody","preferredDefinition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._A human immunodeficiency virus; a species of lentivirus causing leukemia and sometimes a mild immunodeficiency._A human retrovirus associated with T-cell hairy cell leukemia._A type of protein made by B lymphocytes in response to a foreign substance (antigen). Each antibody only binds to a specific antigen, helping to destroy the antigen directly or by assisting white blood cells to destroy the antigen.","longName":"LAB_HTLV_ANTBDY","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2543047","version":"1","preferredName":"Test","preferredDefinition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2262D258-9F2F-4D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-11-16","modifiedBy":"ONEDATA","dateModified":"2006-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2726927","version":"1","preferredName":"HTLV-1 HTLV-2 Antibody","preferredDefinition":"A human immunodeficiency virus; a species of lentivirus causing leukemia and sometimes a mild immunodeficiency.:A human retrovirus associated with T-cell hairy cell leukemia.:(AN-tih-BOD-ee) A type of protein made by certain white blood cells in response to a foreign substance (antigen). Each antibody can bind to only a specific antigen. The purpose of this binding is to help destroy the antigen. Antibodies can work in several ways, depending on the nature of the antigen. Some antibodies destroy antigens directly. Others make it easier for white blood cells to destroy the antigen.","longName":"C14223:C14224:C16295","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HTLV-1","conceptCode":"C14223","definition":"A human deltaretrovirus related to HTLV-2. Human T-lymphotropic virus-1 (HTLV-1) is associated with adult T-cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"HTLV-2","conceptCode":"C14224","definition":"A human deltaretrovirus related to HTLV-1. Although human T-lymphotropic virus-2 (HTVL-2) has been isolated in association with specific diseases it has not been shown to have a causal relationship with any disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Antibody","conceptCode":"C16295","definition":"A type of protein made by B lymphocytes in response to a foreign substance (antigen). Each antibody only binds to a specific antigen, helping to destroy the antigen directly or by assisting white blood cells to destroy the antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"456C153F-F056-2DE7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-02-05","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-02-05","modifiedBy":"ONEDATA","dateModified":"2008-02-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E5A7D87-6400-2015-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-06","endDate":null,"createdBy":"JOSHUAT","dateCreated":"2007-11-07","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2532012","version":"2","preferredName":"Date","preferredDefinition":"The particular day, month and year an event has happened or will happen.","longName":"DATE","context":"NHLBI","contextVersion":"1","type":"Non-enumerated","dataType":"DATE","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"format":"YYYY-MM-DD","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008561","version":"1","preferredName":"Occurrences","preferredDefinition":"dates, times, and durations.","longName":"OCURS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B53BD1AB-090B-398B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-01-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2233081","version":"1","preferredName":"Date","preferredDefinition":"a particular day specified as the time something has, or will, happen.","longName":"C25164","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Date","conceptCode":"C25164","definition":"The particular day, month and year an event has happened or will happen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F90B5E56-BB15-0F45-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-09","modifiedBy":"ONEDATA","dateModified":"2005-06-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A1B282-BBA9-1DAB-E040-BB89AD4319DD","latestVersionIndicator":"Yes","beginDate":"2009-04-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-04-28","modifiedBy":"GDEEN","dateModified":"2024-02-23","changeDescription":"Created new version associated to different CD and Display Format as part of NMDP Date VD clean up 4/2009. mcooper Corrected def from KM change. AK 3/25/19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964896","version":"1","longName":"2004r1: Infectious Disease Markers","context":"NHLBI"}]},{"publicId":"2842777","version":"1","longName":"Labs","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2859933","version":"1","longName":"Infectious Disease Markers (IDMs)","context":"NHLBI"}]}],"AlternateNames":[{"name":"idm_htlv_dte","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Date that the test for human","type":"Preferred Question Text","description":"Date that the test for human T-Lymphotropic virus antibody (Anti-HTLV I / II) was performed:","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"68B6DFB1-B372-5011-E040-BB89AD4322C4","latestVersionIndicator":"Yes","beginDate":"2009-04-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-04-29","modifiedBy":"KUMMEROA","dateModified":"2016-07-07","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}